ModelEdge

PharmaCyte Biotech Inc.
PMCB
Filing Type8-K
Filing Date8/17/2025
Updated8/18/25, 7:20 AM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Reg. FD
EX-3.1FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES C CONVERTIBLE PREFERRED STOCK
EX-4.1FORM OF WARRANT
EX-10.1FORM OF PURCHASE AGREEMENT
EX-10.2FORM OF REGISTRATION RIGHTS AGREEMENT
EX-10.3ENGAGEMENT LETTER, DATED AUGUST 17, 2025 BY AND BETWEEN PHARMACYTE BIOTECH, INC. AND GP NURMENKARI INC.
EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Reg. FD
GRAPHICGraphic